Human immunodeficiency virus type 1 reverse transcriptase

被引:0
|
作者
Hottiger, M [1 ]
Hubscher, U [1 ]
机构
[1] UNIV ZURICH, INST VET BIOCHEM, CH-8057 ZURICH, SWITZERLAND
来源
BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 1996年 / 377卷 / 02期
关键词
enzymatic activity; HIV-1; reverse transcriptase;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Human Immunodeficiency Virus type 1 (HIV-1) is a retrovirus and a causative agent of the Acquired Immune Deficiency Syndrome (AIDS). Retroviruses are distinct from other viruses in their ability to encode an enzyme called reverse transcriptase (RT). The RT is the enzyme mainly involved in replication. It performs RNA- as well as DNA-dependent DNA synthesis in order to convert the single-stranded viral RNA genome into double-stranded DNA. The double-stranded DNA is stably integrated into the host cell genome and is used as a template for the production of a new viral generation. The HIV-1 RT is partially encoded by the POL open reading frame of the HIV-1 genome and consists of two subunits of 66 kDa (p66) and 51 kDa (p51). The p66 polypeptide encodes the reverse transcriptase and the RNase H domain. Half of the p66 molecules are further processed to generate the p51 protein with an identical N-terminus, but lacking the C-terminus which encodes the RNase H domain. In vivo both polypeptides are found in equimolar amounts thus forming a heterodimer. This dimerization is critical for the enzymatic activity. In this review we summarize (i) the replication cycle of HIV-1, (ii) the enzymatic properties of HIV-1 RT and (iii) the structure-function relationship of the HIV-1 RT in view of the known three dimensional structure.
引用
收藏
页码:97 / 120
页数:24
相关论文
共 50 条
  • [41] Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for Use in cDNA Synthesis
    Konishi, Atsushi
    Shinomura, Mayu
    Yasukawa, Kiyoshi
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2013, 169 (01) : 77 - 87
  • [43] KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    DEVREESE, K
    KNOPSGERRITS, PP
    BAEKELANDT, V
    BHIKHABHAI, R
    STRANDBERG, B
    PAUWELS, R
    ANNE, J
    DESMYTER, J
    DE CLERCQ, E
    MOLECULAR PHARMACOLOGY, 1993, 43 (04) : 521 - 526
  • [44] Human immunodeficiency virus mutagenesis during antiviral therapy: Impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies
    Chen, RX
    Yokoyama, M
    Sato, H
    Reilly, C
    Mansky, LA
    JOURNAL OF VIROLOGY, 2005, 79 (18) : 12045 - 12057
  • [45] In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor
    Sato, Akihiko
    Hammond, Jennifer
    Alexander, Therese N.
    Graham, Joanne P.
    Binford, Susan
    Sugita, Ken-ichi
    Sugimoto, Hirohiko
    Fujiwara, Tamio
    Patick, Amy K.
    ANTIVIRAL RESEARCH, 2006, 70 (02) : 66 - 74
  • [46] Human antibodies responsible for binding inhibition and polymerization inhibition of human immunodeficiency virus type 1 reverse transcriptase
    Odawara, F
    Sano, K
    Otake, T
    Okubo, S
    Nakano, T
    Takasaki, T
    Ueba, N
    Misaki, H
    Nakai, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 199 (02) : 175 - 184
  • [47] Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors
    Auwerx, J
    Esnouf, R
    De Clercq, E
    Balzarini, J
    MOLECULAR PHARMACOLOGY, 2004, 65 (01) : 244 - 251
  • [48] Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV
    Wadford, Debra A.
    Kauffman, Robert C.
    Deere, Jesse D.
    Aoki, Scott T.
    Stanton, Richard A.
    Higgins, Joanne
    Van Rompay, Koen K. A.
    Villalobos, Andradi
    Nettles, James H.
    Schinazi, Raymond F.
    Pedersen, Niels C.
    North, Thomas W.
    PLOS ONE, 2014, 9 (01):
  • [49] Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase
    Kaushik, N
    Rege, N
    Yadav, PNS
    Sarafianos, SG
    Modak, MJ
    Pandey, VN
    BIOCHEMISTRY, 1996, 35 (36) : 11536 - 11546
  • [50] The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A
    Auwerx, J
    Rodríguez-Barrios, F
    Ceccherini-Silberstein, F
    San-Félix, A
    Velázquez, S
    De Clercq, E
    Camarasa, MJ
    Perno, CF
    Gago, F
    Balzarini, J
    MOLECULAR PHARMACOLOGY, 2005, 68 (03) : 652 - 659